Related references
Note: Only part of the references are listed.Immunogenicity and humanization of single-domain antibodies
Martin A. Rossotti et al.
FEBS JOURNAL (2022)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Paul-Albert Koenig et al.
SCIENCE (2021)
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity
Alec A. Desai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Nailing Down a Notoriously Elusive Cancer Target: Direct Inhibition of MYC by a Covalent Small Molecule
Matthew J. Henley et al.
CELL CHEMICAL BIOLOGY (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Daniel Wrapp et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford et al.
VIRUSES-BASEL (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec et al.
SCIENCE (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
Xiaojing Chi et al.
NATURE COMMUNICATIONS (2020)
Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs
Ainhoa Moliner-Morro et al.
BIOMOLECULES (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Tania F. Custodio et al.
NATURE COMMUNICATIONS (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
Amanda Sparkes et al.
FASEB JOURNAL (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Biophysical properties of the clinical-stage antibody landscape
Tushar Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Five of Five VHHs Neutralizing Poliovirus Bind the Receptor-Binding Site
Mike Strauss et al.
JOURNAL OF VIROLOGY (2016)
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
Maarten Van Roy et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Mechanism of Action and Capsid-Stabilizing Properties of VHHs with an In Vitro Antipolioviral Activity
Lise Schotte et al.
JOURNAL OF VIROLOGY (2014)
Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge
Francisco Miguel Cardoso et al.
JOURNAL OF VIROLOGY (2014)
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
Yingda Xu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hoetzel et al.
MABS (2012)
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
Lorena Itati Ibanez et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
Anna Hultberg et al.
PLOS ONE (2011)
Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours
U. Iqbal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
Jan Terje Andersen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Transient expression and purification of chimeric heavy chain antibodies
Jianbing Zhang et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
Neha Pant et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Efficient tumor targeting by single-domain antibody fragments of camels
V Cortez-Retamozo et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
